Joseph R. Bertino
Professor & Chief Scientific Officer
The Cancer Institute of NJ, Room 3034
195 Little Albany Street
New Brunswick, NJ 08901
Cell cycle checkpoint control in response to DNA damage, c elegans, zebrafish
Since coming to the Cancer Institute of New Jersey in 2002, I have collaborated with top experts in the field to help develop the latest generation of cancer treatments. I have had a special research interest in developing new drugs and understanding why drugs work or don't work, and I am currently exploring new treatments for one type of lymphoma, namely T- Cell lymphoma. By having the resources available that can only be found at a National Cancer Institute-designated Comprehensive Cancer Center, our team is able to translate these research findings and directly apply them to patient therapies.
With a clinical expertise in lymphoma, I work closely with colleagues across all disciplines at the Cancer Institute, including those within the Leukemia/Lymphoma/Hematologic Malignancies Program, to educate patients about the treatment options available to them.
I completed a USPHS fellowship (in hematology/oncology) at University of Washington School of Medicine. I am a member of the Board of the Lymphoma Research Foundation, which administers grants to promising young investigators. I am the author or co-author of more than 400 scientific publications and I am the associate medical editor of the journal Hem/Onc Today.